BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-175@pharmaconomics
DTSTAMP:20260707T002811Z
DTSTART;VALUE=DATE:20260707
DTEND;VALUE=DATE:20260708
SUMMARY:VERA PDUFA — atacicept
DESCRIPTION:The FDA's approval decision on atacicept for IgA Nephropathy (IgAN) is due Jul 7\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1831828/000119312526073421/vera-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/175
URL:https://pharmaconomics.com/e/175
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:VERA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR